ESMO Congress 2021 : highlights from the EORTC gastrointestinal tract cancer group's perspective
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved..
There has been no major change of practice in gastrointestinal oncology at the European Society for Medical Oncology (ESMO) symposium 2021, but confirmation that immunotherapy in combination with chemotherapy has become standard of care in several indications. The European Organisation for Research and Treatment of Cancer (EORTC) Gastrointestinal Track Cancer Group has selected important phase II and III trials presented during the symposium across all gastrointestinal cancers as well as early reports on new drugs or new combinations that may change practice in the future.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
ESMO open - 7(2022), 2 vom: 01. Apr., Seite 100392 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Koessler, T [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Colorectal cancer |
|---|
| Anmerkungen: |
Date Completed 03.05.2022 Date Revised 06.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.esmoop.2022.100392 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM337125171 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM337125171 | ||
| 003 | DE-627 | ||
| 005 | 20240306232101.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.esmoop.2022.100392 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1318.xml |
| 035 | |a (DE-627)NLM337125171 | ||
| 035 | |a (NLM)35180656 | ||
| 035 | |a (PII)S2059-7029(22)00012-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Koessler, T |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ESMO Congress 2021 |b highlights from the EORTC gastrointestinal tract cancer group's perspective |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.05.2022 | ||
| 500 | |a Date Revised 06.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved. | ||
| 520 | |a There has been no major change of practice in gastrointestinal oncology at the European Society for Medical Oncology (ESMO) symposium 2021, but confirmation that immunotherapy in combination with chemotherapy has become standard of care in several indications. The European Organisation for Research and Treatment of Cancer (EORTC) Gastrointestinal Track Cancer Group has selected important phase II and III trials presented during the symposium across all gastrointestinal cancers as well as early reports on new drugs or new combinations that may change practice in the future | ||
| 650 | 4 | |a Congress | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a colorectal cancer | |
| 650 | 4 | |a neuroendocrine tumours | |
| 650 | 4 | |a oesophagus cancer | |
| 650 | 4 | |a pancreatic cancer | |
| 650 | 4 | |a stomach cancer | |
| 700 | 1 | |a Alsina, M |e verfasserin |4 aut | |
| 700 | 1 | |a Arnold, D |e verfasserin |4 aut | |
| 700 | 1 | |a Ben-Aharon, I |e verfasserin |4 aut | |
| 700 | 1 | |a Collienne, M |e verfasserin |4 aut | |
| 700 | 1 | |a Lutz, M P |e verfasserin |4 aut | |
| 700 | 1 | |a Neuzillet, C |e verfasserin |4 aut | |
| 700 | 1 | |a Obermannova, R |e verfasserin |4 aut | |
| 700 | 1 | |a Peeters, M |e verfasserin |4 aut | |
| 700 | 1 | |a Sclafani, F |e verfasserin |4 aut | |
| 700 | 1 | |a Smyth, E |e verfasserin |4 aut | |
| 700 | 1 | |a Valle, J W |e verfasserin |4 aut | |
| 700 | 1 | |a Wagner, A D |e verfasserin |4 aut | |
| 700 | 1 | |a Wyrwicz, L |e verfasserin |4 aut | |
| 700 | 1 | |a Fontana, E |e verfasserin |4 aut | |
| 700 | 1 | |a Moehler, M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t ESMO open |d 2016 |g 7(2022), 2 vom: 01. Apr., Seite 100392 |w (DE-627)NLM266189539 |x 2059-7029 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2022 |g number:2 |g day:01 |g month:04 |g pages:100392 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.esmoop.2022.100392 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2022 |e 2 |b 01 |c 04 |h 100392 | ||